| Published Application/Species/Sample/Dilution | Reference |
|---|
- flow cytometry; mouse; loading ...; fig 4d
| Theisen D, Davidson J, Briseño C, Gargaro M, Lauron E, Wang Q, et al. WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science. 2018;362:694-699 pubmed publisher |
- flow cytometry; mouse; 1:100; loading ...; fig 4b
| Guimarães G, Gomes M, Campos P, Marinho F, de Assis N, Silveira T, et al. Immunoproteasome Subunits Are Required for CD8+ T Cell Function and Host Resistance to Brucella abortus Infection in Mice. Infect Immun. 2018;86: pubmed publisher |
- flow cytometry; mouse; loading ...; fig 5a
| Black L, Saunderson S, Coutinho F, Muhsin Sharafaldine M, Damani T, Dunn A, et al. The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles. Immunol Cell Biol. 2016;94:430-8 pubmed publisher |
- flow cytometry; mouse; fig 4f
| Kim J, Li W, Choi Y, Lewin S, Verbeke C, Dranoff G, et al. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol. 2015;33:64-72 pubmed publisher |
| Ziegler P, Bollrath J, Pallangyo C, Matsutani T, Canli O, De Oliveira T, et al. Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis. Cell. 2018;174:88-101.e16 pubmed publisher |
| Lybaert L, Ryu K, De Rycke R, Chon A, De Wever O, Vermaelen K, et al. Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-Therapy. Adv Sci (Weinh). 2017;4:1700050 pubmed publisher |
| Kuai R, Ochyl L, Bahjat K, Schwendeman A, Moon J. Designer vaccine nanodiscs for personalized cancer immunotherapy. Nat Mater. 2017;16:489-496 pubmed publisher |
| Song C, Noh Y, Lim Y. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response. Int J Nanomedicine. 2016;11:3753-64 pubmed publisher |
| Ersching J, Basso A, Kalich V, Bortoluci K, Rodrigues M. A Human Trypanosome Suppresses CD8+ T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4+ Foxp3+ T Cells. PLoS Pathog. 2016;12:e1005698 pubmed publisher |
| Wu C, Liu S, Chen H, Shen K, Leng C. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population. Oncotarget. 2016;7:30804-19 pubmed publisher |
| Andersen B, Xia J, Epstein A, Ohlfest J, Chen W, Blazar B, et al. Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant. J Immunother Cancer. 2016;4:11 pubmed publisher |
| Krummey S, Martinez R, Andargachew R, Liu D, Wagener M, Kohlmeier J, et al. Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity. J Immunol. 2016;196:2838-46 pubmed publisher |
| Tähtinen S, Kaikkonen S, Merisalo Soikkeli M, Grönberg Vähä Koskela S, Kanerva A, Parviainen S, et al. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors. PLoS ONE. 2015;10:e0131242 pubmed publisher |
| Tzelepis F, Verway M, Daoud J, Gillard J, Hassani Ardakani K, Dunn J, et al. Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection. J Clin Invest. 2015;125:752-68 pubmed publisher |
| Jang B, Kim H, Kim J, Kim W, Lee B, Kim S, et al. Peptidylarginine deiminase inhibition impairs Toll-like receptor agonist-induced functional maturation of dendritic cells, resulting in the loss of T cell-proliferative capacity: a partial mechanism with therapeutic potential in inflammatory settings. J Leukoc Biol. 2015;97:351-62 pubmed publisher |
| Sreejit G, Ahmed A, Parveen N, Jha V, Valluri V, Ghosh S, et al. The ESAT-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (β2M) affecting antigen presentation function of macrophage. PLoS Pathog. 2014;10:e1004446 pubmed publisher |
| Shen K, Song Y, Chen I, Leng C, Chen H, Li H, et al. Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells. J Immunol. 2014;192:4233-41 pubmed publisher |
| Ramakrishnan R, Tyurin V, Tuyrin V, Veglia F, Condamine T, Amoscato A, et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J Immunol. 2014;192:2920-31 pubmed publisher |
| Imai T, Ishida H, Suzue K, Hirai M, Taniguchi T, Okada H, et al. CD8(+) T cell activation by murine erythroblasts infected with malaria parasites. Sci Rep. 2013;3:1572 pubmed publisher |
| Moreau H, Lemaitre F, Terriac E, Azar G, Piel M, Lennon Dumenil A, et al. Dynamic in situ cytometry uncovers T cell receptor signaling during immunological synapses and kinapses in vivo. Immunity. 2012;37:351-63 pubmed publisher |
| Woller N, Knocke S, Mundt B, Gürlevik E, Strüver N, Kloos A, et al. Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice. J Clin Invest. 2011;121:2570-82 pubmed publisher |
| Hahn S, Setz C, Wild J, Schubert U. The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation. J Immunol. 2011;186:5706-18 pubmed publisher |
| Kwun H, da Silva S, Qin H, Ferris R, Tan R, Chang Y, et al. The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. Virology. 2011;412:357-65 pubmed publisher |
| Porgador A, Yewdell J, Deng Y, Bennink J, Germain R. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity. 1997;6:715-26 pubmed |
